Overview
Far eastern spotted fever, often discussed in context with Mediterranean spotted fever (caused by Rickettsia conorii), is a tick-borne rickettsial infection characterized by fever, rash, and potential severe complications including multiorgan failure 124.Diagnosis
Clinical Presentation: Fever, rash, and flu-like symptoms 124.
Laboratory Tests: Elevated inflammatory markers, thrombocytopenia 4.
Serological Testing: Indirect immunofluorescence assay for Rickettsia antibodies 3.
PCR and Culture: Rarely used but confirmatory if available 2.Management
First-Line Treatment: Doxycycline (adult dose: 100 mg orally twice daily for adults; pediatric dose adjusted by weight) 34.
Duration: Typically 5-7 days 3.
Supportive Care: Fluid resuscitation, monitoring for organ dysfunction, and management of complications (e.g., septic shock, multiorgan failure) 124.
Specific Complications: Address hypocalcemia with calcium supplementation and monitor thyroid function in cases of euthyroid sick syndrome 4.Special Populations
Pediatrics: Increased risk of severe forms with multiorgan failure; doxycycline is generally safe but dose adjustment is crucial 1.
Comorbidities: Patients with underlying conditions may experience more severe presentations, including multiorgan failure and septic shock 24.Key Recommendations
Initiate doxycycline therapy promptly upon suspicion of spotted fever to prevent severe complications (Evidence: Strong 34).
Closely monitor pediatric patients for signs of severe disease progression, including multiorgan failure (Evidence: Moderate 1).
Provide comprehensive supportive care, especially for patients developing septic shock or multiorgan failure, with targeted interventions based on organ dysfunction (Evidence: Moderate 24).References
1 Bota S, de Sousa R, Santos M, Varandas L, Gouveia CF. Severe Israeli spotted fever with multiorgan failure in a child. Ticks and tick-borne diseases 2016. link
2 Demeester R, Claus M, Hildebrand M, Vlieghe E, Bottieau E. Diversity of life-threatening complications due to Mediterranean spotted fever in returning travelers. Journal of travel medicine 2010. link
3 Pedro-Botet J, Auguet T, Pallás O, Gimeno JL. Arthritis in Mediterranean spotted fever. Infection 1991. link
4 Devriendt J, Staroukine M, Amson R, Crockaert F, Dratwa M, Karmali R et al.. Malignant Mediterranean spotted fever. Report of a case with multiple organ failure, hypocalcemia, and euthyroid sick syndrome. Archives of internal medicine 1985. link